NDC properties for NDC 9 55513-283
NDC item 55513028301
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-01 |
| NDC Item | 55513028301 |
| packaging | 2 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 871716 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | active |
NDC item 55513028310
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-10 |
| NDC Item | 55513028310 |
| packaging | 10 VIAL in 1 PACKAGE (55513-283-10) / 2 mL in 1 VIAL (55513-283-01) |
| BLA | BLA103234 |
| FDA SPL set id | 871716 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | ACTIVE |
NDC item 55513028320
| NDC 9 | 55513-283 |
|---|---|
| NDC 10 | 55513-283-20 |
| NDC Item | 55513028320 |
| packaging | 10 VIAL in 1 PACKAGE (55513-283-20) / 2 mL in 1 VIAL (55513-283-01) |
| BLA | BLA103234 |
| FDA SPL set id | 871716 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1994-12-05 |
| Marketing status | active |